3uf8: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_3uf8| PDB=3uf8 | SCENE= }} | {{STRUCTURE_3uf8| PDB=3uf8 | SCENE= }} | ||
===Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with a G95A surface mutation from Burkholderia pseudomallei complexed with FK506=== | ===Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with a G95A surface mutation from Burkholderia pseudomallei complexed with FK506=== | ||
{{ABSTRACT_PUBMED_24366729}} | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/SMT3_YEAST SMT3_YEAST]] Not known; suppressor of MIF2 mutations. | |||
==About this Structure== | ==About this Structure== | ||
[[3uf8]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/ | [[3uf8]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Burp1 Burp1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3UF8 OCA]. | ||
[[Category: | |||
==Reference== | |||
<ref group="xtra">PMID:024366729</ref><references group="xtra"/><references/> | |||
[[Category: Burp1]] | |||
[[Category: Peptidylprolyl isomerase]] | [[Category: Peptidylprolyl isomerase]] | ||
[[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] | [[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] |
Revision as of 16:41, 12 March 2014
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with a G95A surface mutation from Burkholderia pseudomallei complexed with FK506Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with a G95A surface mutation from Burkholderia pseudomallei complexed with FK506
Template:ABSTRACT PUBMED 24366729
FunctionFunction
[SMT3_YEAST] Not known; suppressor of MIF2 mutations.
About this StructureAbout this Structure
3uf8 is a 1 chain structure with sequence from Burp1. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Begley DW, Fox D 3rd, Jenner D, Juli C, Pierce PG, Abendroth J, Muruthi M, Safford K, Anderson V, Atkins K, Barnes SR, Moen SO, Raymond AC, Stacy R, Myler PJ, Staker BL, Harmer NJ, Norville IH, Holzgrabe U, Sarkar-Tyson M, Edwards TE, Lorimer DD. A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob Agents Chemother. 2014 Mar;58(3):1458-67. doi: 10.1128/AAC.01875-13., Epub 2013 Dec 23. PMID:24366729 doi:http://dx.doi.org/10.1128/AAC.01875-13